Your browser doesn't support javascript.
loading
Immune profile and radiological characteristics of progressive multifocal leukoencephalopathy.
Zeiner, Pia S; Mann, Leonhard; Filipski, Katharina; Starzetz, Tatjana; Forster, Marie-Therese; Ronellenfitsch, Michael W; Steinbach, Joachim P; Mittelbronn, Michel; Wagner, Marlies; Harter, Patrick N.
Afiliación
  • Zeiner PS; Dr Senckenberg Institute of Neurooncology, University Hospital, Frankfurt am Main, Germany.
  • Mann L; Department of Neurology, University Hospital, Frankfurt am Main, Germany.
  • Filipski K; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
  • Starzetz T; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Forster MT; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Ronellenfitsch MW; Department of Neurology, University Hospital, Frankfurt am Main, Germany.
  • Steinbach JP; Neurological Institute (Edinger Institute), University Hospital, Frankfurt am Main, Germany.
  • Mittelbronn M; Institute of Neuroradiology, Goethe University, Frankfurt am Main, Germany.
  • Wagner M; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
  • Harter PN; German Cancer Consortium (DKTK), Heidelberg, Germany.
Eur J Neurol ; 29(2): 543-554, 2022 02.
Article en En | MEDLINE | ID: mdl-34644450
ABSTRACT
BACKGROUND AND

PURPOSE:

Progressive multifocal leukoencephalopathy (PML) constitutes a severe disease with increasing incidence, mostly in the context of immunosuppressive therapies. A detailed understanding of immune response in PML appears critical for the treatment strategy. The aim was a comprehensive immunoprofiling and radiological characterization of magnetic resonance imaging (MRI) defined PML variants.

METHODS:

All biopsy-confirmed PML patients (n = 15) treated in our department between January 2004 and July 2019 were retrospectively analysed. Data from MRI, histology as well as detailed clinical and outcome data were collected. The MRI-defined variants of classical (cPML) and inflammatory (iPML) PML were discriminated based on the intensity of gadolinium enhancement. In these PML variants, intensity and localization (perivascular vs. parenchymal) of inflammation in MRI and histology as well as the cellular composition by immunohistochemistry were assessed. The size of the demyelinating lesions was correlated with immune cell infiltration.

RESULTS:

Patients with MRI-defined iPML showed a stronger intensity of inflammation with an increased lymphocyte infiltration on histological level. Also, iPML was characterized by a predominantly perivascular inflammation. However, cPML patients also demonstrated certain inflammatory tissue alterations. Infiltration of CD163-positive microglia and macrophage (M/M) subtypes correlated with PML lesion size.

CONCLUSIONS:

The non-invasive MRI-based discrimination of PML variants allows for an estimation of inflammatory tissue alterations, although exhibiting limitations in MRI-defined cPML. The association of a distinct phagocytic M/M subtype with the extent of demyelination might reflect disease progression.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucoencefalopatía Multifocal Progresiva Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucoencefalopatía Multifocal Progresiva Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur J Neurol Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Alemania
...